Department Of Periodontics, S.R.M. Dental College and Hospital, Chennai, India.
Clin Adv Periodontics. 2024 Sep;14(3):223-231. doi: 10.1002/cap.10266. Epub 2023 Sep 25.
This randomized controlled trial was aimed to evaluate the combined efficacy of injectable platelet-rich fibrin (i-PRF) and scaling and root planing (SRP) in type 2 diabetes mellitus subjects having periodontitis.
Twenty-six Stage III, grade C periodontitis subjects (HbA1c > 7) were recruited in this split-mouth study. Following SRP, the test sites received subgingival application of i-PRF, while the control sites received saline. Plaque index, bleeding on probing, modified gingival index, probing pocket depth (PPD) and clinical attachment level (CAL) were measured at baseline, 3 and 6 months.
Twenty-three participants completed the course of research. The Friedman test followed by Dunn's post hoc test, revealed significant improvement in all the clinical parameters from baseline to 3 and 6 months in both the study groups (p ≤ 0.05). The mean PPD and CAL decreased from 6.30 ± 1.25 and 7.48 ± 1.75 at baseline to 3.48 ± 1.34 and 4.39 ± 1.67 at 6 months in control sites and from 6.57 ± 1.56 and 7.61 ± 1.69 to 3.39 ± 1.23 and 4.26 ± 1.81 at 6 months in test sites (p ≤ 0.0001). Intergroup analysis found no statistical significant differences in the evaluated parameters across all time intervals (p > 0.05) CONCLUSION: The results indicated that the adjunctive application of i-PRF to SRP provided similar benefits as saline and SRP in diabetes mellitus subjects.
Question: To find the combined efficacy of injectable platelet-rich fibrin (i-PRF) along with scaling and root planing (SRP) in the management of periodontal pockets of Stage III and Grade C periodontitis patients having Type 2 Diabetes Mellitus (T2DM).
All of the treated sites showed satisfactory healing. Both the treatment modalities (i-PRF + SRP and Saline + SRP) were effective in the treatment of periodontal pockets. At 3 and 6 months, there were no significant differences in periodontal parameters between groups. Meaning: The application of i-PRF as an adjunct to SRP provided similar benefits as saline and SRP in improving clinical parameters in subjects with stage III and grade C periodontitis patients having T2DM (HbA1C > 7).
本随机对照试验旨在评估注射用富血小板纤维蛋白(i-PRF)联合牙周刮治和根面平整术(SRP)在 2 型糖尿病伴牙周炎患者中的联合疗效。
本研究采用分口设计,共纳入 26 名 III 期 C 级牙周炎(HbA1c>7)患者。在 SRP 后,实验组将 i-PRF 注射到龈下,对照组注射生理盐水。在基线、3 个月和 6 个月时,测量菌斑指数、探诊出血、改良龈沟出血指数、探诊深度(PPD)和临床附着水平(CAL)。
共有 23 名参与者完成了研究。Friedman 检验和随后的 Dunn 事后检验显示,两组的所有临床参数均从基线到 3 个月和 6 个月显著改善(p≤0.05)。对照组的 PPD 和 CAL 分别从基线时的 6.30±1.25 和 7.48±1.75 降至 6 个月时的 3.48±1.34 和 4.39±1.67,实验组分别从 6.57±1.56 和 7.61±1.69 降至 6 个月时的 3.39±1.23 和 4.26±1.81(p≤0.0001)。组间分析发现,在所有时间点,评价参数均无统计学差异(p>0.05)。
结果表明,在 2 型糖尿病患者中,i-PRF 联合 SRP 的应用与单独使用生理盐水和 SRP 具有相似的效果。
问题:探究注射用富血小板纤维蛋白(i-PRF)联合牙周刮治和根面平整术(SRP)在 2 型糖尿病伴牙周炎患者 III 期和 C 级牙周袋治疗中的联合疗效。
所有治疗部位均愈合良好。i-PRF+SRP 和生理盐水+SRP 两种治疗方法均能有效治疗牙周袋。在 3 个月和 6 个月时,两组的牙周参数无显著差异。
在改善 III 期和 C 级牙周炎伴 2 型糖尿病(HbA1C>7)患者的临床参数方面,i-PRF 作为 SRP 的辅助手段,其效果与生理盐水和 SRP 相似。